Deciphering the cellular mechanisms behind ALS
Professor Ernest Fraenkel has decoded fundamental aspects of Huntington’s disease and glioblastoma, and is now using computation to better understand amyotrophic lateral sclerosis.
A noninvasive treatment for “chemo brain”
Stimulating gamma brain waves may protect cancer patients from memory impairment and other cognitive effects of chemotherapy.
Brain surgery training from an avatar
MIT.nano Immersion Lab works with AR/VR startup to create transcontinental medical instruction.
What can super-healing species teach us about regeneration?
Albert Almada PhD ’13 studies the mechanics of how stem cells rebuild tissues. “Digging deep into the science is what MIT taught me,” he says.
New model identifies drugs that shouldn’t be taken together
Using a machine-learning algorithm, researchers can predict interactions that could interfere with a drug’s effectiveness.
Hitchhiking cancer vaccine makes progress in the clinic
MIT spinout Elicio developed a vaccine based on a lymph node-targeting approach first developed at the Koch Institute. Phase 1 solid tumor clinical trial results are promising so far.
Scientists develop a low-cost device to make cell therapy safer
A plastic microfluidic chip can remove some risky cells that could potentially become tumors before they are implanted in a patient.
MIT-led team receives funding to pursue new treatments for metabolic disease
Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.
Doctors have more difficulty diagnosing disease when looking at images of darker skin
Dermatologists and general practitioners are somewhat less accurate in diagnosing disease in darker skin, a new study finds. Used correctly, AI may be able to help.
What to do about AI in health?
Although artificial intelligence in health has shown great promise, pressure is mounting for regulators around the world to act, as AI tools demonstrate potentially harmful outcomes.
Researchers improve blood tests’ ability to detect and monitor cancer
The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.
New hope for early pancreatic cancer intervention via AI-based risk prediction
MIT CSAIL researchers develop advanced machine-learning models that outperform current methods in detecting pancreatic ductal adenocarcinoma.
Turning history of science into a comic adventure
Associate Professor Lydia Bourouiba and artist Argha Manna take readers through a series of discoveries in infectious disease.
Improving patient safety using principles of aerospace engineering
A new MIT study identifies six systemic factors contributing to patient hazards in laboratory diagnostics tests.
Does “food as medicine” make a big dent in diabetes?
Study of rigorous trial shows mixed results, suggests need to keep examining how nutrition can combat a pervasive disease.